Combined hormonal contraceptive Market

Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.
Combined hormonal contraceptive Market contains market size and forecasts of Combined hormonal contraceptive in global, including the following market information:
Global Combined hormonal contraceptive Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Combined hormonal contraceptive Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Combined hormonal contraceptive companies in 2021 (%)
The global Combined hormonal contraceptive market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pills Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Combined hormonal contraceptive include Teva Pharmaceutical Industries, Bayer HealthCare Pharmaceuticals, Actavis, Pfizer, Johnson & Johnson, GlaxoSmithKline, Watson Pharma, Cipla and Novartis International. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Combined hormonal contraceptive manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Combined hormonal contraceptive Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Combined hormonal contraceptive Market Segment Percentages, by Type, 2021 (%)
Pills
Patch
Ring
Global Combined hormonal contraceptive Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Combined hormonal contraceptive Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
E-commerce
Others
Global Combined hormonal contraceptive Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Combined hormonal contraceptive Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Combined hormonal contraceptive revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Combined hormonal contraceptive revenues share in global market, 2021 (%)
Key companies Combined hormonal contraceptive sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Combined hormonal contraceptive sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries
Bayer HealthCare Pharmaceuticals
Actavis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Watson Pharma
Cipla
Novartis International